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Abstract
Adeno-associated virus (AAV) mediates gene targeting in humans by providing exogenous DNA
for allelic replacement through homologous recombination. In comparison to other methods of
DNA delivery or alternative DNA substrates, AAV gene targeting is reported to be very efficient,
perhaps due to its single-stranded DNA genome, the inverted terminal repeats (ITRs), and/or the
consequence of induced cellular signals on infection or uncoating. These viral attributes were
investigated in the presence and absence of an I-Sce endonuclease-induced double-strand break
(DSB) within a chromosomal defective reporter in human embryonic kidney cells. Gene
correction was evaluated using self-complementary (sc) AAV, which forms a duplexed DNA
molecule and results in earlier and robust transgene expression compared with conventional
single-strand (ss) AAV genomes. An scAAV repair substrate was modestly enhanced for reporter
correction showing no dependency on ssAAV genomes for this process. The AAV ITR sequences
were also investigated in a plasmid repair context. No correction was noted in the absence of a
DSB, however, a modest inhibitory effect correlated with the increasing presence of ITR
sequences. Similarly, signaling cascades stimulated upon recombinant AAV transduction had no
effect on plasmid-mediated DSB repair. Noteworthy, was the 20-fold additional enhancement in
reporter correction using scAAV vectors, over ss versions, to deliver both the repair substrate and
the endonuclease. In this case, homologous recombination repaired the defective reporter in 4% of
cells without any selection. This report provides novel insights regarding the recombination
substrates used by AAV vectors in promoting homologous recombination and points to the initial
steps in vector optimization that could facilitate their use in gene correction of genetic disorders.
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Gene targeting is the process in which exogenously delivered nucleic acids are used to
modify a partially homologous target by homologous recombination.1–3 This ability is
largely conserved across kingdoms, and early work in mouse embryonic stem cells showed
gene knockout technology using plasmid DNA for repair.1,4 The transition of this powerful
approach to human genetic correction for therapeutic applications, however, is limited by
the relative inefficiency of the repair process (about one in a million) in addition to
challenges for effective DNA delivery.
Following the cloning of the adeno-associated virus (AAV) genome and subsequent
applications for therapeutic gene addition in humans,5 the recombinant virus was noted to be
enhanced several orders of magnitude for gene targeting, compared with plasmid or alternate
virus-mediated recombination.1,6,7 AAV is a single-strand (ss) DNA dependovirus of the
family, Parvoviridae. The 4.7 kb genome is flanked by 145 nucleotide inverted terminal
repeats (ITRs). In the absence of selection, AAV-induced homologous recombination levels
have been as high as 1%.8 Several reports have characterized this process and note that the
efficiency of the event depends on several factors including (1) type of target mutation, (2)
length of repair homology, (3) position of the site of repair on the AAV genome with respect
to the viral ITRs, (4) cell cycle and (5) chromosomal context.9–12
AAV is efficient for gene targeting perhaps due to nuclear localization of a high number of
genomes, the recombinogenic ITRs and/or the ss nature of the AAV vector template.9
Consistent with the third hypothesis was the observation that duplexed AAV genomes, from
smaller than wild-type packaging cassettes, when mixed with ss genomes, did not contribute
significantly to gene targeting.9 However, the importance of an ss repair substrate is logical,
as no helicase would be necessary for replication protein A binding, followed by
heteroduplex formation, strand exchange or synthesis-dependent strand annealing, and
subsequent opposite strand repair.
Although ss genome dependency for AAV gene targeting represents an attractive
hypothesis, it remains at odds with the observations that both increased time and transduced
genomes enhance this process.8,13 In human cell cultures, ssAAV2 initiates transgene
synthesis soon after infection (green fluorescent protein (Gfp) fluorescence is detectable as
early as 6 h), confirming that at least some AAV genomes are not ss (data not shown
(DNS)). In fact, the duplexed genomes are a natural part of AAV transduction and are
generated in two ways: (1) synthesis of the complementary strand using ITR priming or (2)
by opposite polarity genome annealing (both + and − are packaged at similar
efficiencies).14,15 Although the chosen mechanism appears cell line and tissue specific, it is
also a function of the multiplicity of infection. At higher multiplicity of infections, AAV
genomes likely anneal, yet may still undergo second-strand synthesis, and both processes
would increase over time shifting the equilibrium away from ss and toward duplexed
genomes.15 These considerations suggest that all of the above-mentioned AAV gene
targeting experiments most likely produced a significant mixture of AAV vector DNA
templates (that is, ss or duplexed) making it virtually impossible to assign targeting
efficiency to a particular substrate.8,12 More importantly, circular DNA substrates unrelated
to AAV virion delivery, or the presence of the ITRs, showed nearly identical results from a
direct comparison of ss and duplexed DNA for mammalian gene targeting.16 Similar to
AAV second-strand synthesis, this report also notes synthesis of a complementary strand for
the M13 produced ss circular DNA even in the absence of a mammalian replication origin.16
Hirsch et al. Page 2














To investigate whether ss or duplexed AAV genomes are preferred in gene targeting, we
used our previously described self-complementary (sc) context.17 Such particles harbor a
single DNA molecule with a hinge (mutant ITR) at one end and near-perfect
complementarity thereon.17 Theoretically, these molecules snap back on themselves forming
duplexed DNA. Physiologically, both in cell lines and in vivo, scAAV results in earlier and
dramatically enhanced transgene synthesis compared with conventional ssAAV.17,18
Using a human embryonic kidney cell line containing a chromosome defective gfp reporter
harboring a 35 bp insertion,19 we performed a head to head comparison of ssAAV2 versus
scAAV2 repair substrates (Figure 1). The promoter-less, truncated gfp repair homology of
ssAAV2-gfp repair13 was cloned into an scAAV2 plasmid17 and transduction by either virus
alone does not result in GFP synthesis in unmodified human embryonic kidney cells.13
Production, characterization and quantitation of all recombinant AAV vectors were as
described.20 Southern blot analysis of both the ss and scAAV2-gfp repair genomes was used
as an additional control (Figure 1a). The purity of the respective viral genomes was nearly
100%.
Given the results of others13 and preliminary experiments (DNS), we chose a ratio of 10 000
genome-containing particles (gcps) per cell. Gfp+ cells after transduction by either virus
were scarce, regardless of the nature of the repair genome (Figure 2b). However, a modest
increase was noted for scAAV over ssAAV, with targeting values of 0.004 and 0.002%,
respectively. From these experiments, Gfp+ cells were isolated by fluorescence-activated
cells sorting and sequence analysis of ten clones from either group (ss or sc) suggested error-
free homologous recombination as the mechanism of repair (DNS).
Many reports using various technologies agree that a local double-strand break (DSB)
increases targeted gene correction.21–26 Thus, due to the inadequate targeting efficiency of
AAV for human therapy applications, we investigated the enhancement of this process by a
DSB generated by a yeast-derived endonuclease, I-SceI (Sce). Conveniently, the 35 bp insert
of the defective gfp cell line harbors the Sce recognition sequence and cleavage at this site
results in 4 nt 3′ overhangs.19 Co-transduction of an ssAAV2-CMV-Sce,13 along with
ssAAV2-gfp repair (10 000 gcp per cell of each virus), resulted in an approximate 100-fold
increase in the amount of cells positive for Gfp (Figure 1b). Consistent to the results without
the break, scAAV2-gfp repair resulted in a twofold enhancement in Gfp+ cells. Transduction
by ssAAV2-Sce along with a nonhomologous ssAAV2 target repair vector yielded no false
positives in 105 cells (DNS).
In nearly all cases, transduction by scAAV results in rapid and robust transgene expression
when compared with the ss equivalent.17 Therefore, we evaluated this observation for Sce
by packaging it in the sc format.17 Genome purity of the ss and scAAV2-Sce variants was
near 100% as determined by Southern blot analysis (Figure 2a). Gfp+ cells were quantitated
following co-transduction of scAAV2-gfp repair and either ss or scAAV2-Sce (10 000 gcp
per cell of each virus). Delivery of Sce in the sc context resulted in a therapeutic level of
reporter activity (3–4%) that was increased 2000-fold over ssAAV2-gfp repair gene
targeting in the absence of an induced break (Figure 2b). The dramatic effect of scAAV2-
Sce compared with the ss version correlated to increased Sce abundance (Figure 2c). In
addition, the targeting efficiency likely underrepresents the actual value, as it is not
normalized to AAV2 co-transduction. In other experiments using the same capsid, cells and
gcp/cell ratio, this value was approximated at 80–85% (DNS).
Because the ss nature of the AAV genome did not enhance repair, compared with the
duplexed version, we also investigated the role of the ITRs in this process. To determine if
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the AAV ITR sequence stimulates DSB repair, we cloned the identical gfp repair homology
into plasmid constructs containing no ITR, one ITR27 or between two ITRs.28 These
substrates were compared for their ability to repair the defective gfp cell line containing the
35 bp insertion. Co-transfection of either repair plasmid, along with a plasmid expressing
Sce13 at a ratio of 4:1, respectively, showed a slight decrease in Gfp+ cells inversely
correlated with increasing number of ITRs present (Figure 3). Although the double-strand
plasmid context of the ITRs is different from that of viral genomes, these data suggest that
the ITRs solely do not stimulate targeted DSB repair of the host chromosome, despite the
likelihood of being processed to a DSB by host repair enzymes as reported.29 This result is
perhaps consistent with a report describing no contribution of AAV ITRs to chromosome
integration (in a double-strand plasmid context) in vivo.30
As the ss nature of the AAV genome appears not required for efficient AAV targeting, nor
do the isolated ITR sequences placed next to repair homology, it was hypothesized that
AAV-induced signaling cascades originating from particle binding, trafficking and/or
uncoating influence the efficiency of the event. For example, AAV transduction induces a
DNA damage response that arrests cells at the G2/M checkpoint31 and results in the altered
expression of cell-cycle regulators including p21WAF and several cyclin proteins.32 In
addition, empty AAV capsids elicited similar changes in the expression of these regulators,
suggesting that signaling cascades, initiated from binding or entry, altered regulation as
these particles do not accumulate in the nucleus and do not contain an AAV genome
(DNS).32 Therefore, the ability of a plasmid, containing two ITR sequences flanking the gfp
repair homology mentioned above, to repair a chromosomal DSB was investigated during
the infection of an ssAAV vector that has no target or repair homology. For these
experiments, Gfp+ cells were quantitated 3 days after a co-transfection then transduction
scheme, or vice versa. The co-transfection event used both the ITR repair plasmid and the
CMV-SceI expression plasmid given either 12 h before or after ssAAV2-TTR-F9 infection
at the indicated multiplicity of infections (Figure 4). In either regimen, no significant effect
of plasmid-mediated DSB correction of the host chromosome was observed upon
nonhomologous AAV infection at different gcp/cell ratios.
Discussion
Herein, we tested a standing hypothesis that the ss nature of the AAV genome is necessary
for AAV gene correction.9 This assertion is sensible as an ssAAV genome could directly
compete for annealing at its chromosomal target site without requiring the assistance of a
helicase for strand unwinding (as would be necessary for duplexed repair substrates).
However, the results herein show that scAAV genomes also mediate gene correction, and at
a level slightly increased compared with the ss equivalent. Although significant, the twofold
increase in targeting efficiency of sc over ssAAV was modest, and could simply be
explained by the fact that the sc genomes actually have two copies of repair homology in
opposite polarities on a single molecule.17 Another possible explanation for scAAV
genomes serving as templates for homologous recombination is that in addition to the
mechanisms of chromosomal repair induced by ss genomes, such as gene conversion,
duplexed genomes can also undergo double crossover events. Observations of increased
stability of the scAAV genomes could also result in increased targeting efficiencies.18
Perhaps more promising from a therapeutic standpoint is the ability to increase AAV
targeting efficiencies using a local DSB13 (Figure 1). As the Sce site is not found in the
human genome, much effort is focused on the generation of designer endonucleases (that is
Zn-finger endonucleases, homing endonucleases and so on) that can be tailored for
recognition and cleavage at a specific chromosomal site.19,33,34 Although the efficiencies of
these enzymes for target cleavage varies, gene correction values have been reported near
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20%.34 However, concerns remain as to the toxicity of designer endonucleases as DSBs can
induce apoptosis and, depending on the binding efficiency of the endonuclease, off-target
cutting may occur. Therefore, transient expression of these molecules is preferred, as well as
obligate nuclease heterodimerization domains.35,36 As such, the direct application of this
technology to in vivo applications is unlikely. Thus, ex vivo manipulations of human stem
cells represents a more attractive approach, especially given the ability to direct their
differentiation.37 Therefore, it seems possible to repopulate an individual with their own
cells that have been genetically modified with the greatest barrier being selection of the
relatively rare event or achieving a high enough correction efficiency to avoid the
difficulties and problems associated with clonal isolation and outgrowth. For this purpose,
use of AAV packaged with an sc genome may be preferable as the capsid can be tailored for
transduction of many cell types and unwanted vector genome integration is inherently
minimal and can be further reduced.38,39
Materials and methods
Maintenance of cells
A human embryonic kidney cell line, having a defective gfp reporter integrated into the
chromosome, was used for all experiments, unless indicated, and was described
previously.19 All cells were grown in Dulbecco’s modified Eagle’s medium supplemented
with 10% heat-inactivated fetal bovine serum and 1 × Penn/Strep (DMEM+; Sigma, St
Louis, MO, USA). Cells were maintained at 37 °C in a 5% CO2 humidified incubator.
AAV production and characterization
All vectors used in this study were produced using a triple transfection protocol followed by
CsCl gradient centrifugation and dialysis in 1 × phosphate-buffered saline solution as
previously described.20 The ssAAV production plasmids for CMV-Sce and the gfpR
homology were also previously described.13 To create the scAAV versions of these
plasmids, we cloned the identical sequence elements (CMV-Sce or gfpR) into the pHpa-Trs-
SK plasmid previously described.17 In all cases, these recombinant AAV genomes were
packaged in the AAV serotype 2 capsids. Virus titer was determined by Southern dot blot
and Southern alkaline gel electrophoresis as previously described.20
rAAV transduction
A total 50 000 293 cells were seeded in a 24-well plate 24 h before transduction. The next
day, the indicated amount of virus particles was diluted in 50 µl of DMEM+ before well
addition. At the indicated time point (usually 72 h), cells were harvested by gentle
aspiration, washed in phosphate-buffered saline and resuspended in phosphate-buffered
saline for immediate flow cytometric analysis. In the experiments described herein, the co-
transduction efficiency was not explicitly determined, thus the experimental results were not
corrected for co-transduction and likely underrepresent the actual values. All experiments
were performed in triplicate on at least three different days, and the results were presented as
the averages of the experimental data.
Western blot
Sample preparation for western analysis followed standard techniques.20 An unlabeled
primary antibody against the N-terminal HA-Tag on Sce was used as recommended by the
manufacturer (Abcam, Cambridge, MA, USA). An anti-rabbit IgG antibody conjugated to
horse-radish peroxidase was used as the secondary antibody and blots were developed using
a chemiluminescent substrate kit as recommended by the manufacturer (Pierce, Rockford,
IL, USA).
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Analysis of Gfp+ cells
Gfp+ cells were visualized by fluorescent microscopy and quantitated by flow cytometry at
the indicated time points. A minimum of 100 000 similar sized/shaped single cells were
counted, for each replicate, at the indicated times at an event per second rate of 1500–2000.
The Gfp+ gate was designed such that untreated cells did not give a single Gfp+ event
beyond a million counted cells. It was also positioned away from false, or transitioning, Gfp
+ cells to obtain no false positives. Gfp+ cells were isolated by fluorescence-activated cell
sorting for single cells and the corrected gfp sequence of 10 Gfp+ clones was confirmed by
direct sequencing (DNS, primer sequences available upon request).
Plasmid transfections
In these experiments (performed on cells in a 24-well format), 1 µg of plasmid DNA was
diluted in DMEM without supplements, vortexed in the presence of PEI and the mixture was
added to the well 10 min later. Under these conditions, transfection of an equivalent amount
of a CMV-Gfp expression plasmid results in 80% Gfp+ cells.
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AAV gene targeting is stimulated by a local double-strand break. (a) Southern blot analysis
of purified single-strand (ss) or (sc) AAV2-gfp repair (R) genomes. The grouped columns
show consecutive twofold dilutions. An illustration depicts a possible conformation of the
genomes and in each case gfpR homology is identical (5′ homologous arm is 0.25 kb and the
3′ homologous arm is 1 kb). The ssAAV genome also contains 2.1 kb of stuffer DNA
sequence located downstream of the gfp repair homology for a total genome size of 3.4 kb.
The scAAV genome contains stuffer DNA sequence as well, 0.46 kb upstream and 0.29 kb
downstream of the gfp repair homology (final genome size of about 4 kb). (b) The defective
gfp 293 cell line was infected with either ss or sc AAV2-gfp repair (R) at a gcp/cell ratio of
10 000. Simultaneously, cells were also transduced by another vector, either ssAAV2-
factor9 repair (no double-strand break (no −DSB)) or ssAAV2-Sce (+DSB) at 10 000 gcp
per cell. Gfp+ cells were quantitated by flow cytometry at the indicated times.
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Self-complementary AAV mediates efficient endonuclease delivery for increased AAV-
mediated double-strand break repair. (a) Southern analysis of AAV2 capsid isolated single-
strand (ss) or (sc) Sce genomes. (b) The defective gfp 293 cell line described in the text was
co-transduced by (sc) AAV2-gfp repair (R) along with either ss or scAAV2-Sce (10 000
genome-containing particles for each virus). Gfp+ cells were quantitated by flow cytometry
at the indicated times. (c) Western blot analysis of the Sce protein. Two days after co-
transduction of the vectors mentioned in a, cell lysates were prepared and analyzed for Sce
by western blotting using an antibody to the N-terminal HA tag. The lanes marked with a
symbol ‘−’ represent cells that were transduced only by scAAV-gfpR. A nonspecific band is
common to all lanes and serves as a loading control.
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AAV inverted terminal repeat sequences do not enhance plasmid-mediated double-strand
break repair. The defective gfp 293 cell line (35 bp insertion) described in the text was
transfected with plasmids containing identical gfp repair homology and either 0, 1 or 2 AAV
inverted terminal repeat sequences (ITRs). At the same time, cells were also given a plasmid
expressing the Sce endonuclease. At the indicated time points, Gfp+ cells were quantitated
by flow cytometry.
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AAV transduction does not affect plasmid DSB repair. (a) The defective gfp 293-cell line
mentioned in the text was co-transfected with gfp repair and Sce expression plasmids. After
12 h of transfection, the cells were infected with AAV2-TTR-F9 at the indicated gcps per
cell. This virus has no significant homology to the defective gfp target. (b) The same cells
were first infected with AAV2-TTR-F9 at the indicated gcps and then transfected with the
gfp repair and Sce expression plasmids at either 1 or 12 h after infection. In both a and b,
Gfp+ cells were quantitated by flow cytometry 48 h after the initial treatment.
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